S Sone|E Tsubura - JoVE Visualize

Showing results (81-90 of 436) with videos related to

Pageof 44

Sort By:

No to Hattatsu = Brain and Development|September 1, 1990

[Vestibular function in severely retarded children in relation to their motor disabilities]S Sone, H Suzuki, Y Hirayama, et al.

Journal of Leukocyte Biology|January 1, 1993

Induction of a 26-kDa membrane-form tumor necrosis factor (TNF)-alpha in human alveolar macrophagesA Nii, S Sone, E Orino, et al.

International Journal of Cancer|August 22, 1996

Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patientsA Yamamoto, E Shimizu, T Ogura, et al.

Japanese Journal of Cancer Research : Gann|October 1, 1992

Inhibition by fibrin coagulation of lung cancer cell destruction by human interleukin-2-activated killer cellsS Atagi, S Sone, K Fukuta, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1991

A novel differentiation antigen on human monocytes that is specifically induced by granulocyte-macrophage colony-stimulating factor or IL-3K Maeda, S Sone, Y Ohmoto, et al.

Journal of the National Cancer Institute|March 1, 1985

Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal stateS Sone, G Lopez-Berestein, I J Fidler

Japanese Journal of Cancer Research : Gann|November 1, 1985

Induction of human monocyte-mediated tumor cell killing by a plant lectin, wheat germ agglutininM Ogawara, T Utsugi, M Yamazaki, et al.

Cancer Immunology, Immunotherapy : CII|March 31, 1998

Generation of killer activity by interleukin-12 of mononuclear cells in malignant pleural effusions due to lung cancerK Hiramatsu, H Yanagawa, T Haku, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987

Effects of human alveolar macrophages on the induction of lymphokine (IL 2)-activated killer cellsS Sone, T Utsugi, A Nii, et al.

Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1986

[Augmentation of natural killer (NK) cell activity in human blood lymphocytes by a new synthetic acyltripeptide (FK-565) and its derivatives]E Shimizu, P Tandon, T Utsugi, et al.

Pageof 44

Showing results (81-90 of 436) with videos related to

Sort By:

Pageof 44

No to Hattatsu = Brain and Development|September 1, 1990

[Vestibular function in severely retarded children in relation to their motor disabilities]S Sone, H Suzuki, Y Hirayama, et al.

Journal of Leukocyte Biology|January 1, 1993

Induction of a 26-kDa membrane-form tumor necrosis factor (TNF)-alpha in human alveolar macrophagesA Nii, S Sone, E Orino, et al.

International Journal of Cancer|August 22, 1996

Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patientsA Yamamoto, E Shimizu, T Ogura, et al.

Japanese Journal of Cancer Research : Gann|October 1, 1992

Inhibition by fibrin coagulation of lung cancer cell destruction by human interleukin-2-activated killer cellsS Atagi, S Sone, K Fukuta, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1991

A novel differentiation antigen on human monocytes that is specifically induced by granulocyte-macrophage colony-stimulating factor or IL-3K Maeda, S Sone, Y Ohmoto, et al.

Journal of the National Cancer Institute|March 1, 1985

Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal stateS Sone, G Lopez-Berestein, I J Fidler

Japanese Journal of Cancer Research : Gann|November 1, 1985

Induction of human monocyte-mediated tumor cell killing by a plant lectin, wheat germ agglutininM Ogawara, T Utsugi, M Yamazaki, et al.

Cancer Immunology, Immunotherapy : CII|March 31, 1998

Generation of killer activity by interleukin-12 of mononuclear cells in malignant pleural effusions due to lung cancerK Hiramatsu, H Yanagawa, T Haku, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987

Effects of human alveolar macrophages on the induction of lymphokine (IL 2)-activated killer cellsS Sone, T Utsugi, A Nii, et al.

Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1986

[Augmentation of natural killer (NK) cell activity in human blood lymphocytes by a new synthetic acyltripeptide (FK-565) and its derivatives]E Shimizu, P Tandon, T Utsugi, et al.

Pageof 44